<DOC>
	<DOCNO>NCT02076477</DOCNO>
	<brief_summary>This study evaluate optimal intervention time radiotherapy oligometastatic stage iv lung cancer .</brief_summary>
	<brief_title>The Optimal Intervention Time Radiotherapy Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>18 75 year old , male female Pathologically cytologically proven oligometastatic stage IV NSCLC nonsmall cell lung cancer（NSCLC） Primary tumor measure Distant organ metastasis number ≤ 5 Karnofsky score &gt; 70 , Zubrod performance status 01 Estimated life expectancy least 12 week reproductive age woman ensure enter study period contraception Hemoglobin≥10.0g/dL , WBC≥ 4000 cells/mm³ , Platelet count≥100,000 cells/mm³ Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 2.5 time upper limit normal , bilirubin normal Creatinine normal OR creatinine clearance ≥ 60 mL/min Patients good compliance treatment followup acceptance . Allergic pemetrexed , cisplatin , docetaxel contrast medium Distant metastases organ &gt; 5 The primary tumor lymph node already receive surgical treatment ( except biopsy ) Patient receive radiotherapy primary tumor lymph node Patient receive epidermal growth factor target therapy Patient receive chemotherapy immunotherapy Patient suffer malignant tumor Patient take drug test within 1 month Pregnant woman Lactating Women Women productive age refuse take contraception observation period Subject severe allergic history idiosyncratic Subject severe pulmonary cardiopathic disease history Refuse incapable sign inform consent form participate trial Drug abuse alcohol addict Subject Personality psychiatric disease , people legal capacity people limited capacity civil conduct</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>intervention time</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>oligometastatic</keyword>
	<keyword>non-small cell lung cancer</keyword>
</DOC>